Selecta Biosciences, Inc. (SELB): Price and Financial Metrics

SELB POWR Grades

• Value is the dimension where SELB ranks best; there it ranks ahead of 87.7% of US stocks.
• SELB's strongest trending metric is Quality; it's been moving up over the last 179 days.
• SELB's current lowest rank is in the Growth metric (where it is better than 2.87% of US stocks).

SELB Stock Summary

• Of note is the ratio of SELECTA BIOSCIENCES INC's sales and general administrative expense to its total operating expenses; just 10.75% of US stocks have a lower such ratio.
• Over the past twelve months, SELB has reported earnings growth of -126.97%, putting it ahead of merely 12.33% of US stocks in our set.
• As for revenue growth, note that SELB's revenue has grown -23.43% over the past 12 months; that beats the revenue growth of only 9.84% of US companies in our set.
• If you're looking for stocks that are quantitatively similar to SELECTA BIOSCIENCES INC, a group of peers worth examining would be BOLT, TSVT, RGNX, IKNA, and KDNY.
• SELB's SEC filings can be seen here. And to visit SELECTA BIOSCIENCES INC's official web site, go to selectabio.com.

SELB Valuation Summary

• In comparison to the median Healthcare stock, SELB's price/sales ratio is 58.82% lower, now standing at 2.1.
• SELB's price/earnings ratio has moved down 4.9 over the prior 84 months.

Below are key valuation metrics over time for SELB.

SELB Growth Metrics

Its 4 year net cashflow from operations growth rate is now at -72.7%.
• The 4 year net income to common stockholders growth rate now stands at -36.5%.
• Its 4 year cash and equivalents growth rate is now at 169.6%.

Over the past 49 months, SELB's revenue has gone up $123,902,000.

The table below shows SELB's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	123.919	-51.242	41.725
2022-06-30	127.636	-66.341	31.724
2022-03-31	108.026	-60.113	27.688
2021-12-31	85.077	-60.382	-25.687
2021-09-30	67.091	-36.172	-53.372
2021-06-30	47.31	40.211	-45.207

SELB's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• SELB has a Quality Grade of B, ranking ahead of 76.01% of graded US stocks.
• SELB's asset turnover comes in at 0.269 -- ranking 167th of 682 Pharmaceutical Products stocks.
• QGEN, ALPN, and TXMD are the stocks whose asset turnover ratios are most correlated with SELB.

The table below shows SELB's key quality metrics over time.